These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 4558038)

  • 1. [Isolation, purification and physical chemical properties of proteocin D52].
    Popova GA; Kretova AF; Tikhonenko AS; Goriachenkova EV
    Mikrobiologiia; 1972; 41(3):442-8. PubMed ID: 4558038
    [No Abstract]   [Full Text] [Related]  

  • 2. Electron microscopy studies of complex of proteocin D52 Proteus mirabilis and antibody.
    Kretova AF; Popova GA; Tikhonenko AS
    Immunochemistry; 1971 Nov; 8(11):1007-10. PubMed ID: 4110100
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electron microscopic study of the structure of complexes of Proteus mirabilis proteocin D52 with specific antibodies].
    Kretova AF; Popova GA; Tikhonenko AS
    Dokl Akad Nauk SSSR; 1972 Apr; 203(5):1183-5. PubMed ID: 4553948
    [No Abstract]   [Full Text] [Related]  

  • 4. Physical properties and the fine structure of proteocines.
    al-Jumaili IJ
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(4):421-32. PubMed ID: 983532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The purification, structure and synthesis of proticine 3.
    Senior BW
    J Med Microbiol; 1983 Aug; 16(3):323-31. PubMed ID: 6348290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilization and purification of a cytoplasmic membrane bound enzyme catalyzing tetrathionate and thiosulphate reduction in Proteus mirabilis.
    Oltmann LF; Schoenmaker GS; Stouthamer AH
    Arch Mikrobiol; 1974 Jun; 98(1):19-30. PubMed ID: 4599885
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electron microscopic study of the fine structure and intracellular development of defective phage D52 in Proteus mirabilis cells].
    Tikhonenko AS; Bespalova IA; Beliaeva NN
    Mikrobiologiia; 1971; 40(1):128-32. PubMed ID: 5580108
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of bacteriocinogenic types of strains of Proteus mirabilis].
    Józefowicz-Piatkowska H; Piatkowski K
    Med Dosw Mikrobiol; 1994; 46(3):151-60. PubMed ID: 7996932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electron microscopic aspects concerning the adsorption of Proteus mirabilis phage "22" on Proteus mirabilis is bacterial strain.
    Petrovici A; Năcescu N; Constantinescu SP; Israil A
    Arch Roum Pathol Exp Microbiol; 1980; 39(2):179-84. PubMed ID: 6998413
    [No Abstract]   [Full Text] [Related]  

  • 10. Purification and properties of the Proteus mirabilis catalase.
    Jouve HM; Tessier S; Pelmont J
    Can J Biochem Cell Biol; 1983 Jan; 61(1):8-14. PubMed ID: 6342724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting the unique biophysical properties of bacteriocins to purify Bac 1829 from Staphylococcus aureus KSI1829.
    Crupper SS; Iandolo JJ
    Protein Expr Purif; 1997 Mar; 9(2):228-32. PubMed ID: 9056488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proticin types of Proteus mirabilis strains isolated from various environments].
    Nieradko J
    Przegl Epidemiol; 1976; 30(1):41-5. PubMed ID: 775565
    [No Abstract]   [Full Text] [Related]  

  • 13. Proticine typing of serologically defined Proteus strains.
    Csiszár K; Lányi B
    Acta Microbiol Acad Sci Hung; 1981; 28(1):111-8. PubMed ID: 7020353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Total protein amino acid composition of bacterial and stable L forms of Proteus mirabilis D52].
    Ivanova E; Toshkov A; Sotirov N; Gumpert J
    Acta Microbiol Bulg; 1984; 15():24-30. PubMed ID: 6385639
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sensitization of guinea pigs with L and S forms of Proteus mirabilis D52].
    Toshkov A; Kenarova B; Ivanova E; Gumpert I
    Acta Microbiol Bulg; 1982; 11():86-90. PubMed ID: 6763463
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibiotic and inhibiting effect of proteus].
    Kerasheva SI; Rakhtanova EP; Zvereva NM
    Antibiotiki; 1973 Mar; 18(3):236-9. PubMed ID: 4587462
    [No Abstract]   [Full Text] [Related]  

  • 17. [Detection of bacteriocin production by Proteus mirabilis. Proposal for a new protocol for bacteriocin typing].
    Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández Crehuet M; Cueto Espinar A; Piédrola Angulo G
    Rev Latinoam Microbiol; 1984; 26(4):299-303. PubMed ID: 6395246
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization and serological classification of O-specific polysaccharide of Proteus mirabilisTG 276-90 from Proteus serogroup O34.
    Kołodziejska K; Siwińska M; Zych K; Rózalski A; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):223-6. PubMed ID: 16736109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural alterations to Proteus mirabilis as a result of exposure to haemolymph from the larvae of Galleria mellonella.
    Morton DB; Barnett RI; Chadwick JS
    Microbios; 1984; 39(157-158):177-85. PubMed ID: 6374385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathological anatomy and pathogenesis of small intestine lesions due to opportunistic enterobacteria (Proteus and Klebsiella)].
    Barshteĭn IuA; Anisimova IuN; Gandziĭ GP
    Arkh Patol; 1982; 44(7):18-24. PubMed ID: 6751293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.